Course of menopause in women living with HIV

Course of menopause in women living with HIV - OPINION 1

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00020924

Enrollment

180

Registered

2022-11-09

Start date

2019-10-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B24

Interventions

Group 1: HIV positive women: Approval from the Ethics Committee of the Department of Medicine at Frankfurt University Hospital: 13.03.2019 Funding decision of the BMG: 16.10.2020 Creation of bookle

Eligibility

Sex/Gender

Female

Age

45 Years to 60 Years

Inclusion criteria

Inclusion criteria: HIV positive and HIV negative women between 45 and 60 years

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

Measure	Time frame
Age of onset and course of menopause in women living with HIV. Determination of the severity of the symptoms using the score of the Menopause Rating Scale (MRS)	—

Secondary

Measure	Time frame
• Clinical and laboratory chemical parameters • Data on antiretroviral therapy • Comparison of age at onset of menopause and course of perimenopause in HIV-positive and negative women	—

Countries

Germany

Contacts

Public ContactAnnette Haberl

Universitätsklinikum Frankfurt Zentrum der Inneren Medizin Klinik II - HIVCENTER

Annette.Haberl@hivcenter.de+49 (0)69 6301-7680

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026